4 terminated. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 3 | 1 | Terminated 1 |
Follow Hemangioma, Capillary: new trials by email Literature Review of Hemangioma, Capillary trials Research Report on Hemangioma, Capillary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TKI 258 in Von Hippel-Lindau Syndrome (VHL) Dovitinib - Von Hippel-Lindau Syndrome | Phase 2 | Terminated | M.D. Anderson Cancer Center | 6 | 2012-11-01 | 2017-02-13 |
| Propranolol in Capillary Hemangiomas propranolol treatment, placebo treatment - Hemangioma, Capillary | Phase 2 / Phase 3 | Terminated | University Hospital, Bordeaux | 14 | 2008-10-01 | 2026-06-01 |
| The Effects of Aldara as an Adjunct to Laser Treatment Imiquimod, non-medicated petroleum cream - Port Wine Stains | Phase 2 | Terminated | Henry Vasconez | 7 | 2008-10-01 | 2018-03-22 |
| Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow SU011248 - Von Hippel-Lindau Syndrome, Renal Cell Carcinoma | Phase 2 | Terminated | M.D. Anderson Cancer Center | 15 | 2006-05-01 | 2024-06-27 |
Hemangioblastoma (2) · von Hippel-Lindau Disease (2) · Carcinoma, Renal Cell (1) · Central Nervous System Neoplasms (1) · Cysts (1) · Neoplasms (1) · Pigmentation Disorders (1)
Hemangioma (4) · Neoplasms by Histologic Type (4) · Neoplasms, Vascular Tissue (4) · Neoplasms (3) · Abnormalities, Multiple (2) · Angiomatosis (2) · Cardiovascular Diseases (2) · Ciliopathies (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Neoplasms by Site (2) · Nervous System Diseases (2) · Neurocutaneous Syndromes (2)
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one (1) · Imiquimod (1) · Sunitinib (1)
M.D. Anderson Cancer Center (2) · Henry Vasconez (1) · University Hospital, Bordeaux (1)
United States (3) · France (1)
Eric Jonasch, MD (2) · Henry C. Vasconez, MD (1) · Nicholas Moore, Professor (1)
PMID 22105611, PMID 23301692, PMID 26813215, PMID 29571951, PMID 34783716
2008 (1)